Latin America In Vitro Diagnostics Market

The Latin America in vitro diagnostics (IVD) market is projected to grow from an estimated USD 5.87 billion in 2026 to USD 8.13 billion by 2031, at a CAGR of about 6.7%. The growing prevalence of infectious and chronic diseases, combined with the increasing focus on diagnostic testing by both public and private healthcare sectors, has led to a higher demand for these tests. Additionally, there is a rising awareness of the importance of early disease diagnosis. Ongoing investments in laboratory infrastructure, along with greater access to and adoption of automated solutions in diagnostic testing, are further enhancing testing capabilities and driving growth in the Latin America IVD market.

In June 2025, Sysmex Corporation (Japan) announced the relocation and expansion of its diagnostic reagent production facility in Brazil, aiming to further strengthen its long-term supply capability in response to business growth in Central and South America.

To know about the assumptions considered for the study download the pdf brochure

In January 2025, bioMérieux (France) acquired Neoprospecta (Brazil), a company specializing in advanced microbiological analysis, including next-generation DNA sequencing and biocomputational analysis. This acquisition will enhance bioMérieux's capabilities in advanced microbial diagnostics.

Companies such as F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (US), Danaher (US), Siemens Healthineers AG (Germany), bioMérieux (France), Thermo Fisher Scientific Inc. (US), QuidelOrtho Corporation (US), Illumina Inc. (US), Becton, Dickinson and Company (US), Agilent Technologies, Inc. (US) and others have adopted various strategies to expand their offerings and increase their market share. These strategies include collaborating on projects with other companies, acquiring other businesses, developing new products or services, and establishing contracts with partners.

F. Hoffmann-La Roche Ltd. (Switzerland) is a leading player in the IVD market in Latin America. The company consistently invests in diagnostic innovation and adds advanced testing platforms to its portfolio. The company has a diversified portfolio in infectious diseases, tissue diagnostics, oncology, and diabetes care, with test volumes spread across the various clinical testing needs of patients in LATAM. Roche is advancing its strategic initiatives, including product innovation and technology advancement, to consolidate its market position.

Abbott (US) is a key company in the Latin American IVD market due to its strong presence in POC, immunoassays, and core laboratory diagnostics, all of which are widely used in hospitals, clinics, and other healthcare settings in the region. With a wide range of tests, Abbott is well-equipped to support both routine screening and disease monitoring for infectious and chronic conditions, ensuring consistent usage. Additionally, the company reinforces its leadership position in Latin America by emphasizing reliable and user-friendly diagnostic platforms, alongside a well-established regional distribution and service capability.

Market Ranking

F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (US), Danaher (US), Siemens Healthineers AG (Germany), and bioMérieux (France) are some key players in the IVD market across Latin America because of their wide diagnostic portfolios and continuous technological improvements.

Roche offers innovative solutions in molecular diagnostics, laboratory automation, and personalized healthcare for diseases related to oncology and diabetes testing. Abbott has established a strong market presence for immunoassays, point-of-care diagnostics, and clinical chemistry testing platforms. Danaher is a major provider of a very vast and broad range of diagnostic instruments, reagents, and workflow solutions, all supported by a very large global manufacturing and distribution network. Siemens Healthineers manufactures cutting-edge diagnostic innovations across immunoassay, hematology, and automated laboratory workflows, facilitating streamlined operations. bioMérieux specializes in microbiology & MDx, developing solutions widely utilized for the diagnosis of infectious diseases and therapeutic decisions in hospitals, clinics, and clinical labs.

Related Reports:

Latin America In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Disease) - Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com